Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer
Technology appraisal guidance
Reference number: TA212
Published:
Colorectal cancer (metastatic) - bevacizumab: consultee and commentator comments on the ACD